WG
NTUS

Winton Group’s Natus Medical Inc NTUS Stock Holding History

Winton Group’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-26,566
Closed -$871K – 1132
2022
Q2 		$871K Sell
26,566
-1,942
-7% -$61.4K 0.05% 522
2022
Q1 		$749K Sell
28,508
-621
-2% -$15.2K 0.04% 563
2021
Q4 		$691K Buy
29,129
+4,549
+19% +$112K 0.04% 579
2021
Q3 		$616K Sell
24,580
-872
-3% -$22.2K 0.03% 754
2021
Q2 		$661K Buy
25,452
+1,043
+4% +$28.4K 0.04% 757
2021
Q1 		$625K Buy
24,409
+2,266
+10% +$58.1K 0.04% 750
2020
Q4 		$444K Buy
22,143
+4,171
+23% +$81.7K 0.03% 851
2020
Q3 		$308K Buy
+17,972
New +$340K 0.01% 1240
2020
Q2 		– Sell
-22,525
Closed -$521K – 1637
2020
Q1 		$521K Sell
22,525
-1
-0% -$29 0.01% 1017
2019
Q4 		$743K Buy
22,526
+14,031
+165% +$450K 0.01% 1135
2019
Q3 		$270K Buy
+8,495
New +$248K ﹤0.01% 1313

Other funds holding NTUS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Winton Group's NTUS Position: Q3 2022 in Review

Winton Group sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 26,566 shares — an estimated $871K sold.

Winton Group first reported a position in NTUS in Q3 2019 and held it in 11 quarters. The position peaked at $871K in Q2 2022. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.

  • Winton Group reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
  • Winton Group sold 26,566 Natus Medical Inc shares in Q3 2022, an estimated $871K.
  • Winton Group first reported a position in Natus Medical Inc in Q3 2019 and held it in 11 quarters.
  • Winton Group's Natus Medical Inc position peaked at $871K in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.

Based on Winton Group's 13F filing for Q3 2022, filed 10 Nov 2022.